Actually, Jess, they do, or at least they used to. Back in the day, HB always had webcasts after Pona data releases at conferences. After Oct. 2013, that practice ended except for maybe once, I recall. I guess they are feeling really good about this one.
", so I would speculate that the update would be a good one designed to expedite approval of this BIC drug."
Jess, your post above extracted from one of your recent posts would indicate that an update from Ariad could possibly expedite the approval by the FDA of Brigatinib. Unfortunately that is not the case..
News 
Market Data 
Discover 
